PACB PACIFIC BIOSCIENCES OF CALIFORNIA
Industrials · Russell 2000
Next earnings: not announced yet
What 10 analyst firms say about PACIFIC BIOSCIENCES OF CALIFORNIA: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
9 rated views · 10 analyst/firm records · 10 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 5 reports on PACB from 4 analyst firms in the last 90 days (10 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target.
No firm's latest available rating differs from its previous one.
Latest observed target change: Barclays raised its target from $1.25 (set 7 Oct 2026) to $2.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Luke E Sergott | Sell | 7 Oct 2026 | 1.25 USD |
| Canaccord Genuity | Kyle Mikson | Buy | 8 May 2026 | 3.00 USD |
| Guggenheim | Subbu Nambi | Hold | 2 Apr 2026 | — |
| Jefferies | Tycho W Peterson | Buy | 1 Jul 2026 | 3.00 USD |
| Piper Sandler | David M Westenberg | Hold | 4 Aug 2026 | 2.00 USD |
| Stephens | Mason Carrico | Buy | 6 Aug 2026 | 1.50 USD |
| TD Cowen | Daniel Brennan | Buy | 15 Jun 2026 | 3.00 USD |
| UBS | Doug Schenkel | Hold | 9 Sep 2026 | Conflicting reports · excluded |
| Weiss Ratings | Unnamed analyst | — | 13 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 20 Apr 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.